This ICR is approved per CMS's 10/15/08 memo and revised form. CMS shall ensure that the Spanish-language version is similarly revised before its issuance.
Inventory as of this Action
Requested
Previously Approved
10/31/2011
36 Months From Approved
11/30/2008
290,344
0
1,056,000
145,172
0
528,000
0
0
53,000
Pursuant to 42 CFR 423.568(c) and (d), if a Part D plan denies drug coverage it must give the enrollee written notice of the adverse coverage determination. The form and content of the written notice must comport with specific requirements.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.